DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Contract Manufacturing Market Research Report by Service, End-user, and Region – Global Forecast to 2026 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.
The Global Pharmaceutical Contract Manufacturing Market size was estimated at USD 89.91 billion in 2020, is expected to reach USD 97.17 billion in 2021, and projected to grow at a CAGR of 8.33% reaching USD 145.35 billion by 2026.
Market Dynamics
Drivers
- Rising Demand for Generics and Biological Therapies
- Increasing Investments in Pharmaceutical R&D and Manufacturing
- Increasing Number of CMOs and Rising Investments in Advanced Manufacturing Technologies
Restraints
- Introduction of Serialization Standards
Opportunities
- Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector
- Growing Demand for Cell and Gene Therapies for Targeted Treatment
Challenges
- Changing Trade Policies Between Countries
Market Segmentation & Coverage
This research report categorizes the Pharmaceutical Contract Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
- Based on Service, the market was studied across Biologics Manufacturing Services, Drug Development Services, Pharmaceutical Manufacturing Services, and Secondary Packaging Services. The Biologics Manufacturing Services is further studied across Biologics API Manufacturing Services and Biologics FDF Manufacturing Services. The Pharmaceutical Manufacturing Services is further studied across Pharmaceutical API Manufacturing and Pharmaceutical FDF Manufacturing. The Pharmaceutical API Manufacturing is further studied across Capsule Manufacturing Services, Oral Liquid Manufacturing Services, Parenteral/Injectable Manufacturing Services, and Tablet Manufacturing Services.
- Based on End-user, the market was studied across Big Pharma, Generic Pharmaceutical Companies, and Small & Mid-Size Pharma.
- Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom
The report provides insights on the following:
- Market Penetration: Provides comprehensive information on the market offered by the key players
- Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
- Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
- Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
- Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
- What is the market size and forecast of the Global Pharmaceutical Contract Manufacturing Market?
- What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Contract Manufacturing Market during the forecast period?
- Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Contract Manufacturing Market?
- What is the competitive strategic window for opportunities in the Global Pharmaceutical Contract Manufacturing Market?
- What are the technology trends and regulatory frameworks in the Global Pharmaceutical Contract Manufacturing Market?
- What is the market share of the leading vendors in the Global Pharmaceutical Contract Manufacturing Market?
- What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Contract Manufacturing Market?
Company Profiles:
- AbbVie, Inc.
- Aenova Group GmbH
- Almac Group
- Amgen Inc.
- AMRI Global
- Baxter International Inc.
- Biozoc Inc.
- C. H. Boehringer Sohn AG & Co. KG
- Cambrex Corporation
- Catalent, Inc.
- Danaher Corporation
- Dr. Reddy’s Laboratories Ltd.
- Evonik Industries AG
- Famar Health Care Services
- Fareva
- Jubilant Life Sciences Limited
- Kryptochem Medicament Pvt. Ltd.
- Lonza Group
- Mitsubishi Tanabe Pharma Corporation
- Pfizer Inc.
- Pidolma Healthcare
- Recipharm AB
- Serum Institute of India Ltd.
- Siegfried Holding AG
- Sycon Healthcare
- Thermo Fisher Scientific Inc.
- Vetter Pharma International GMBH
For more information about this report visit https://www.researchandmarkets.com/r/s0ux9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900